Literature DB >> 3821926

On the nature of the receptor mediating the action of 5-hydroxytryptamine in potentiating responses of the mouse urinary bladder strip to electrical stimulation.

S E Holt, M Cooper, J H Wyllie.   

Abstract

Superfused mouse bladder strip responded to electrical stimulation (ES) by twitch contractions. These contractions were potentiated by 5-hydroxytryptamine (5-HT; 0.03-3.0 microM). Three tryptamine analogues were tested for their ability to potentiate the responses to ES and their relative activities were compared with values in the literature. 5-Carboxamidotryptamine was more potent than 5-HT, N-omega-methyl 5-HT was about equipotent, and alpha-methyl 5-HT was much less potent. Exogenous noradrenaline did not reduce the effect of 5-HT, although it reduced the response of the tissue to ES. The maximum increase in tissue tension evoked by 5-HT was unaltered by phentolamine (1 microM) or bretylium (25 microM). These results show that 5-HT did not act on the bladder by inhibiting the release of catecholamines from intrinsic nerves. The effect of 5-HT proved very resistant to attempts to block it with conventional 5-HT antagonists. Several antagonists were studied including ketanserin, methysergide, methiothepin, and MDL 72222 but even at concentrations as high as 1 microM none of them exhibited any marked inhibitory effect against the action of 5-HT. At 10 microM some compounds showed activity, but none abolished the effect except methiothepin - and its action was not surmountable by increasing the concentration of 5-HT. Thus the effect of 5-HT on the bladder was not mediated by 5-HT receptors of types 'M', 'D' or 5-HT2.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3821926     DOI: 10.1007/bf00569366

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Direct evidence for an interaction of beta-adrenergic blockers with the 5-HT receptor.

Authors: 
Journal:  Nature       Date:  1977-05-19       Impact factor: 49.962

2.  The relative potency of 5-hydroxytryptamine like substances.

Authors:  G BERTACCINI; P ZAMBONI
Journal:  Arch Int Pharmacodyn Ther       Date:  1961 Aug-Sep

3.  A pendulum auxotonic lever.

Authors:  W D PATON
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

4.  Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.

Authors:  D Hoyer; G Engel; H O Kalkman
Journal:  Eur J Pharmacol       Date:  1985-11-26       Impact factor: 4.432

5.  Evidence for a presynaptic inhibitory receptor for 5-hydroxytryptamine in dog isolated saphenous vein [proceedings].

Authors:  W Feniuk; P P Humphrey; A D Watts
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

6.  Multiple 3H-5-hydroxytryptamine binding sites in rat brain.

Authors:  D L Nelson; N W Pedigo; H I Yamamura
Journal:  J Physiol (Paris)       Date:  1981

7.  A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists.

Authors:  W Feniuk; P P Humphrey; M J Perren; A D Watts
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

8.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09

9.  Two kinds of tryptamine receptor.

Authors:  J H GADDUM; Z P PICARELLI
Journal:  Br J Pharmacol Chemother       Date:  1957-09

10.  MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

Authors:  J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

View more
  8 in total

1.  Proceedings of the British Pharmacological Society. Oxford, 9th-11th September 1987. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

2.  Evidence for the presynaptic action of 5-hydroxytryptamine and the involvement of purinergic innervation in the rabbit lower urinary tract.

Authors:  H I Chen
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

3.  Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.

Authors:  S M Candura; E Messori; G P Franceschetti; G D'Agostino; D Vicini; M Tagliani; M Tonini
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  Pharmacological analysis of agonist-antagonist interactions at acetylcholine muscarinic receptors in a new urinary bladder assay.

Authors:  P A Durant; N P Shankley; N J Welsh; J W Black
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

5.  Pharmacological analysis of 5-hydroxytryptamine effects on electrically stimulated human isolated urinary bladder.

Authors:  M Corsi; C Pietra; G Toson; D Trist; G Tuccitto; W Artibani
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

6.  5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.

Authors:  E Messori; C A Rizzi; S M Candura; A Lucchelli; B Balestra; M Tonini
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

7.  Responses to 5-hydroxytryptamine evoked in the hemisected spinal cord of the neonate rat.

Authors:  L A Connell; D I Wallis
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

8.  Demonstration of 5-HT(3) receptor function and expression in the mouse bladder.

Authors:  N Chetty; I M Coupar; R Chess-Williams; K P Kerr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-07-03       Impact factor: 3.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.